Table 2.
Synopsis of the main diagnostic criteria proposed for Parkinson’s disease, in terms of methodology, size, and relative diffusion.
| Reference | Year of publication | Diagnostic features | Size (no. of pages) | Diffusion |
|---|---|---|---|---|
| James Parkinsona (1) | 1817 | Clinical | 66 | +++ |
| Gibb and Leesb (10) (UKPDSBB) | 1988 | Clinical | 44 | +++ |
| Calne et al.a (11) | 1992 | Clinical | 3 | + |
| Larsen et al.a (12) | 1994 | Clinical | 10 | + |
| Gelb et al.a (13) | 1999 | Clinical | 7 | ++ |
| EFNS/MDS-ESc (18) | 2013 | Clinical and laboratory | 19 | ++ |
| MDSa (21, 41) | 2015 | Clinical and laboratory | 9 | +++(?) |
Type of study: asingle- or multi-expert opinion; bSingle center clinicopathological study; cSystematic review.
EFNS/MDS-ES, European Federation of Neurological Societies/Movement Disorders Society-European Section; UKPDSBB, United Kingdom Parkinson’s disease society brain bank clinical diagnostic criteria; MDS, Movement Disorder Society.